Reneo stockholders approve all proposals for OnKure merger at special meeting

OnKure Therapeutics, Inc.

Proposal 1 (stock issuance for merger) approved: 21.87M for, 110.6K against.
Proposal 2 (PIPE stock issuance >20%) approved: 21.87M for, 110.7K against.
Proposal 4 (reverse stock split) approved: 21.85M for, 131.9K against.
Proposals 5 and 6 (NewCo equity plans) approved by 17.48M and 18.38M votes for.
All seven proposals passed; adjournment not needed as quorum and votes were sufficient.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.